In agreement with this observation, we found that the sensitivity of NSCLC cell lines to the CLTC inhibitor PITSTOP2 also correlated with stathmin pathway activity (Fig. 6b). The gene discussed is CLTC; the disease is non-small cell lung carcinoma.